STAT+: Pharma is a ‘mixed bag’ when providing drug access to low- and middle-income countries, analysis finds

AI Summary

An analysis finds that pharmaceutical companies’ efforts to expand medicine access in low- and middle-income countries have produced mixed results. Many large firms have taken steps to improve access, but progress remains uneven.

Many large pharmaceutical companies are taking steps to improve access to their medicines in low- and middle-income countries, but progress has been mixed.